The Seroepidemiology of Haemophilus influenzae Type B Prior to Introduction of an Immunization Programme in Kathmandu, Nepal. [PDF]
Haemophilus influenzae type b (Hib) is now recognized as an important pathogen in Asia. To evaluate disease susceptibility, and as a marker of Hib transmission before routine immunization was introduced in Kathmandu, 71 participants aged 7 months-77 ...
Neelam Adhikari +43 more
core +2 more sources
Cost-effectiveness of Haemophilus influenzae type b conjugate vaccine in low- and middle-income countries: regional analysis and assessment of major determinants. [PDF]
OBJECTIVES: To estimate the cost-effectiveness of Haemophilus influenzae type b (Hib) conjugate vaccine in low- and middle-income countries and identify the model variables, which are most important for the result.
Clark, Andrew +2 more
core +1 more source
Update on Selected Adverse Events of Concern Following Immunization With Acellular Pertussis Vaccines, a Narrative Review. [PDF]
ABSTRACT Aim To provide an update paper on evidence of adverse events of concern following immunization (AEFI) with pertussis vaccines, focusing primarily on acellular (aP) vaccines. Methods Evidence was synthesised from epidemiological studies, systematic reviews over recent decades, expert interpretations in reviews from relevant research teams and ...
Nilsson L, Storsaeter J.
europepmc +2 more sources
Haemophilus influenzae Type b (Hib) Vaccines
It is now more than 30 years since Haemophilus influenzae type b (Hib) conjugate vaccine was first introduced into the routine infant immunization schedule in Finland, and the vaccine is now used in all European countries.
Slack, MPE
core +1 more source
Background In the pre-vaccine era, invasive disease with Haemophilus influenzae, type b (Hib) commonly presented with osteoarticular involvement. Haemophilus influenzae, type a (Hia) sepsis is a rare but emerging problem in recent years.
Tiffany Albrecht +5 more
doaj +1 more source
Economic evaluation of delivering Haemophilus influenzae type b vaccine in routine immunization services in Kenya. [PDF]
OBJECTIVE: Haemophilus influenzae type b (Hib) vaccine was introduced into routine immunization services in Kenya in 2001. We aimed to estimate the cost-effectiveness of Hib vaccine delivery. METHODS: A model was developed to follow the Kenyan 2004 birth
Akumu, Angela Oloo +3 more
core +1 more source
The evidence for non-typeable Haemophilus influenzae as a causative agent of childhood pneumonia
Haemophilus influenzae type b (Hib) was a major cause of bacterial pneumonia in children prior to the introduction of Hib-conjugate vaccines. The widespread use of Hib-conjugate vaccines has resulted in a significant decline in the number of cases of ...
Mary P E Slack
doaj +1 more source
Background High rates of vaccination coverage are important in preventing infectious diseases. Enforcing mandatory vaccinations is one of the strategies that some Countries adopted to protect the community when vaccination coverage is not satisfactory ...
Elena Bozzola +5 more
doaj +1 more source
A phase III randomized double-blind placebo-controlled trial was conducted in the urban neighborhoods of Delhi to assess whether Oral Rotavirus Vaccine ROTAVAC® interferes with the immune response to childhood vaccines when coadministered. Infants aged 6
Temsunaro Rongsen Chandola +13 more
doaj +1 more source
Haemophilus influenzae microarrays: virulence and vaccines [PDF]
AbstractIn 1995 the genome sequence of the Haemophilus influenzae KW20 (Rd) strain was published, the first available for a free‐living organism. The genome has been invaluable in global strategies to identify certain virulence‐related genes, e.g.
Ali, Tahir R. +2 more
openaire +2 more sources

